Curis, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.
Company’s product profile: Erivedge®
“Previous animal studies have indicated that Erivedge® is embryotoxic and teratogenic. The FDA-approved labeling thus carries a boxed warning stating that Erivedge® can cause fetal harm when administered to pregnant women and recommends the use of contraception during and after treatment.”
Curis, Inc. is a biotechnology company, which is focused on the development and commercialization of innovative drug candidates for the treatment of human cancers. Its pipeline includes is CUDC-907, an orally-available, small molecule inhibitor of histone deacetylase, or HDAC, and phosphatidylinositol-3-kinase, or PI3K enzymes. It conducts research programs both internally and through strategic collaborations. The company was founded on February 14, 2000 and is headquartered in Lexington, MA. [Source: MarketWatch]
Company Website: http://www.curis.com